REVIVAL Trademark

Trademark Overview


On Monday, May 25, 2020, a trademark application was filed for REVIVAL with the United States Patent and Trademark Office. The USPTO has given the REVIVAL trademark a serial number of 79297218. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 20, 2022. This trademark is owned by AM-Pharma B.V.. The REVIVAL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases; inflammatory diseases, kidney diseases, deficiency diseases; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, deficiency diseases, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders

Scientific and technological services, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely scientific research, analysis, and reporting in the field of medicine and pharmaceutical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases, autoimmune diseases; industrial analysis and industrial research in the field of medicine and drug development for treating infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; product development of technologies, diagnostics, pharmaceuticals, biotechnological research related to enzymatic synthesis; testing, authentication and quality control of pharmaceuticals for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research services; research and development s...
revival

General Information


Serial Number79297218
Word MarkREVIVAL
Filing DateMonday, May 25, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 20, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized word "REVIVAL" in blue with four curved bands over the letters "VIV" all in a gradient of turquoise, evoking a rainbow; the color white in the mark represents background or transparent areas only and is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical and medical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases; inflammatory diseases, kidney diseases, deficiency diseases; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, deficiency diseases, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders
Indication of Colors claimedThe color(s) blue and turquoise is/are claimed as a feature of the mark.
Goods and ServicesScientific and technological services, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely scientific research, analysis, and reporting in the field of medicine and pharmaceutical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases, autoimmune diseases; industrial analysis and industrial research in the field of medicine and drug development for treating infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; product development of technologies, diagnostics, pharmaceuticals, biotechnological research related to enzymatic synthesis; testing, authentication and quality control of pharmaceuticals for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development services; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; clinical and medical research; scientific research for medical purposes, namely conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 6, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAM-Pharma B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNL

Trademark Events


Event DateEvent Description
Sunday, November 12, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 20, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 20, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, October 20, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 20, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, October 20, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, April 24, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, April 7, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 7, 2022FINAL REFUSAL E-MAILED
Thursday, April 7, 2022FINAL REFUSAL WRITTEN
Wednesday, April 6, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 6, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, January 10, 2022ASSIGNED TO EXAMINER
Thursday, May 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 20, 2020REFUSAL PROCESSED BY IB
Sunday, November 29, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, November 29, 2020REFUSAL PROCESSED BY MPU
Wednesday, November 11, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 10, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 10, 2020APPLICATION FILING RECEIPT MAILED
Friday, November 6, 2020ASSIGNED TO EXAMINER
Friday, November 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 5, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB